| Bio Roundup: Grail Acquisition, Libra’s Launch, Tau Trial Results & More | Frank Vinluan | 09/25/20 | National |
| Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More | Frank Vinluan | 04/24/20 | National |
| Silverback Therapeutics Adds $79M to Test HER2+ Tumor-Targeting Drug | Sarah de Crescenzo | 03/11/20 | Seattle |
| Bio Roundup: Little Rhody, More for Migraine, Opioid Bills & More | Alex Lash | 09/21/18 | National |
| Last Chance to Save on What’s Hot in Seattle Biotech | Jamie Gulden | 06/05/18 | National |
| What’s Hot in Seattle Biotech: Here’s the Agenda for the June 12 Event | Frank Vinluan | 05/21/18 | Seattle |
| Grab the Early Bird Rate for What’s Hot in Seattle Biotech on June 12 | Jamie Gulden | 04/17/18 | National |
| Get the Inside Scoop on Seattle Life Sciences at Xconomy’s June Event | Jamie Gulden | 03/29/18 | National |
| VCs Poured $300M into Seattle Area Companies in Q1, Up 33 Percent | Benjamin Romano | 04/05/17 | Seattle |
| West Coast Biotech Roundup: Theranos, Medivation, Juno, and More | Alex Lash | 04/15/16 | San Francisco |
